Rare diseases
Investigational molecules
Locations
A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
BelgiumStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
BelgiumA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
BelgiumSacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy
BelgiumA study of the effects of nirmatrelvir, ritonavir, and rosuvastatin in healthy adult participants
BelgiumEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
BelgiumRelative Bioavailability of Pitolisant Tablets in Healthy Male Subjects for Narcolepsy Treatment
BelgiumEfficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy
BelgiumEfficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial
BelgiumSafety, Tolerability and Pharmacokinetics of MK-7480 and Diltiazem Hydrochloride in Healthy Adult Male Participants for Non‑alcoholic Steatohepatitis
BelgiumEvaluation of safety and efficacy of 19CP02 combined with cyclophosphamide and fludarabine phosphate in adults with treatment‑refractory active systemic lupus erythematosus
BelgiumA study evaluating glofitamab and a drug combination for patients with relapsed or refractory diffuse large B-cell lymphoma.
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
